R&D Capability

The company has the core technology by making continuous and independent innovation.

As technological innovation is the fundamental driving force for enterprise development, YOCON always adheres to the R&D policy of being “safer, more convenient, and more economical”, and has been perfecting its technology over the years. For the molecular diagnostic product line, YOCON has independently developed rare “Class II” virus sampling kits, lysis-free nucleic acid extraction reagents, and automatic sample processing and nucleic acid extraction workstations in China. For the cell culture media product line, it has successfully developed dozens of cell culture reagents such as serum-free media for MSC and NK cells, gentle digestive enzymes for stem cells, and serum-free cell freezing medium. The protein-free chemically defined medium and automatic cell culture workstation under development are in the final stages, and their launch will bring new changes. The R&D facilities of the company cover an area of 3,000 m2, with 9 Class 10,000 clean GMP laboratories. Two physicochemical laboratories are available. The laboratories are equipped with an ultra-fast triple quadrupole liquid chromatography-mass spectrometer, flow cytometer, fluorescence quantitative PCR instrument, large bioreactor, inverted fluorescence microscope, biosafety cabinet, etc. YOCON has the core technology by making continuous and independent innovations to make steady progress in the fields of cell therapy and molecular diagnosis.